The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the ...

A government crackdown on cheaper copies of Ozempic and similar diabetes and weight-loss drugs was intended to shut the door on that booming market. It hasn’t exactly worked out that way.

Similarly, in an article penned by dental hygienist Anne Symons and published in the British Dental Nurses’ Journal (BDNJ), she outlines that “there is not sufficient evidence to suggest that ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

It’s been nicknamed “Ozempic feet,” when those shedding pounds on the injectable drugs find that the skin on their feet is ...

But only Wegovy is FDA approved for this use. Both drugs are approved for lowering cardiovascular risks, and Ozempic is approved for type 2 diabetes. This article explains how Ozempic and Wegovy ...

The Therapeutic Goods Administration has received complaints of blindness and vision loss in one eye among users of Ozempic and Wegovy ... be aware of whether side effects may be temporary ...